Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane
Sponsor
University Hospital, Ghent (Other)
Overall Status
Completed
CT.gov ID
NCT00230906
Collaborator
Nissho Nipro Europe (Other)
12
1
14.9
0.8
Study Details
Study Description
Brief Summary
Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane
Study Start Date
:
Jan 1, 2001
Actual Study Completion Date
:
Apr 1, 2002
Outcome Measures
Primary Outcome Measures
- Concentration of uremic components after 3 weeks of haemodialysis []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Chronic haemodialysis patient
-
Serum albumin > 3.6 g/dl
Exclusion Criteria:
- < 18 years
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University Hospital Ghent | Ghent | Belgium | 9000 |
Sponsors and Collaborators
- University Hospital, Ghent
- Nissho Nipro Europe
Investigators
- Principal Investigator: Raymond Van Holder, MD, PhD, University Hospital, Ghent
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00230906
Other Study ID Numbers:
- 2001/182
First Posted:
Oct 3, 2005
Last Update Posted:
Dec 28, 2007
Last Verified:
Dec 1, 2007